Progressive autonomic failure (DBCOND0089527)

Identifiers

Synonyms
Pure Autonomic Failure (PAF) / Pure Autonomic Failure / Shy-Drager syndrome / Autonomic failure progressive / Pure autonomic failure (disorder) / Autonomic failure syndrome

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Droxidopa
A medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03829657
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failuretreatment3terminated
NCT05489575
CPAP for the Treatment of Supine HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT00775853
Biomarkers of Risk of Parkinson DiseaseNot AvailableNot Availablecompleted
NCT04620382
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patientsother0recruiting
NCT03482297
Automated Abdominal Binder for Orthostatic Hypotensiontreatment1 / 2recruiting
NCT01044693
Nebivolol in the Supine Hypertension of Autonomic FailureNot AvailableNot Availablecompleted
NCT02417415
Local Heat Stress in Autonomic Failure Patients With Supine HypertensionNo drug interventionsotherNot Availablecompleted
NCT04246437
[18F]F-DOPA Imaging in Patients With Autonomic Failurebasic_science1recruiting
NCT00178919
Nitric Oxide and the Autonomic Nervous SystemNot AvailableNot Availablecompleted
NCT01119417
The Role of Endothelin in the Supine Hypertension of Autonomic Failureother1withdrawn
NCT00742586
Autonomic Failure Patients for RNA Blood SamplingNo drug interventionsNot AvailableNot Availablecompleted
NCT02640339
Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04700722
Synuclein-One StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02429557
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failureother1recruiting
NCT01316666
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic HypotensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02591173
Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failuretreatment0terminated
NCT03681080
Concentration and Attentional Deficits in POTS and Other Autonomic NeuropathiesNo drug interventionssupportive_careNot Availablecompleted
NCT01927055
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapytreatment3terminated
NCT03042988
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT01799915
Natural History Study of SynucleinopathiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04875949
Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)No drug interventionssupportive_careNot Availablecompleted
NCT02897063
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failurebasic_science1recruiting
NCT04782830
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension SymptomsotherNot Availablerecruiting
NCT01292694
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failurebasic_science1terminated
NCT01607268
Magnetic Resonance Spectroscopy in Autonomic FailureNo drug interventionsNot AvailableNot Availableterminated
NCT02705755
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)treatment2completed
NCT00179023
The Autonomic Nervous System and Obesitydiagnostic1completed